0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Gene Therapy Cell Culture Media Market Size & Share, Growth Trends, Report by Media Type, Viral Vectors Type, and End User: Global Opportunity Analysis and Industry Forecast, 2020–2027
Published Date: January 2021
|
Report Code: ALLI-Auto-3U448
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Gene Therapy Cell Culture Media Market by Media Type Serum Containing Media Serum Free Media Stem Cell Media Specialty Media Chemically Defined Media Lysogeny Broth Custom Media and Others Viral Vectors Type Retroviruses Lentiviruses Adenoviruses Adeno Associated Virus Herpes Simplex Virus Poxvirus Vaccinia Virus and Others and End User Biotechnology Pharmaceutical Industry Academic Institute Research Laboratory and Others Global Opportunity Analysis and Industry Forecast 2020 2027

Gene Therapy Cell Culture Media Market Size & Share, Growth Trends, Report by Media Type, Viral Vectors Type, and End User: Global Opportunity Analysis and Industry Forecast, 2020–2027

Code: ALLI-Auto-3U448
Report
January 2021
262 Pages
Allied Market Research
Region: Global,
Description
Table of Content
Tables & Figures

Gene Therapy Cell Culture Media Market Outlook - 2027

The global gene therapy cell culture media market accounted for $122.60 million in 2019 and is expected to reach $278.96 million by 2027, registering a CAGR of 10.6% from 2020 to 2027. Due to the COVID-19 pandemic, the gene therapy cell culture media companies are largely protected from economic disruption, owing to an increase in demand for media such as improved protein-free media for the growth and production of viral vectors. In addition, the rise in demand for COVID vaccines through gene and cell therapy propels the market growth. Furthermore, many gene therapy companies may see the opportunity to find vaccines for Covid-19 as life support which increases the demand for gene therapy cell culture media market as its wider use in clinical trials.
Gene Therapy Cell Culture Media Market Size, Share, Research Report
 
Gene therapy cell culture media consists of important nutrients that provide ample energy to regulate the healthy cell cycle. Moreover, it contains bovine serum, animal-derived nutrients, and growth factors like EGF, FGF, IGF, and PDGF. A surge in R&D activities worldwide is a prime factor for the growth of the gene therapy cell culture media. Various pharmaceutical and biotechnology companies are heavily investing in the R&D of gene therapy. Culture media are nutrient growth substances provided in laboratory and research settings for growth, proliferation, maintenance, and storage of microorganisms and other cell types such as stem cells, mammalian, and other cell lines. Different culture media are available in the market for various cell cultures to survive and grow in their incubation environment.
 
Viral vectors include all viruses that can be used as vectors for the transfer of genes into a host cell. These vectors are further categorized into retroviruses, lentiviruses, adenoviruses, adeno-associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others. Many gene therapy clinical trials have been conducted that make use of retroviruses or adenoviruses to deliver the desired gene. These viruses vary in regards with the mechanism of transferring the genes to those cells which they can recognize and then they infect, which leads to change in the cell’s DNA permanently or temporarily.
 
The market growth is driven due to factors such as rise in R&D investments, and growth in awareness regarding gene therapy. However, dearth of skilled professionals, high costs associated with gene therapies, and ethical & scientific concerns associated with culture media hamper the market growth. Moreover, untapped potential of the emerging economies is expected to offer opportunities for gene therapy cell culture market growth during the forecast period.
 
The segment is divided into media type, viral vectors type, end user, and region. By media type is further divided into serum containing media, serum free media, stem cell media, specialty media, chemically defined media, lysogeny broth, custom media, and others. In addition, the viral vectors are divided into retroviruses, lentiviruses, adenoviruses, adeno associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others. Further, by end user, the market is classified into biotechnology & pharmaceutical industry, academic institute, research laboratory, and others. By region, the gene therapy cell culture media market size is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
 
The gene therapy cell culture media market provides extensive competitive analysis and profiles of key market players, such as Fujifilm Holdings Corporation, HiMedia Laboratories Pvt., Ltd, Lonza Group Ltd, Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Takara Holdings Inc., Novartis International AG, and Bio-Techne Corporation.

Key Benefits for Stakeholders

  • This report entails a detailed quantitative analysis of the current market trends from 2019 to 2027 to identify the prevailing opportunities.
  • The gene therapy cell culture media market size and estimations are based on comprehensive analysis of the key developments in the industry.
  • In-depth analysis based on region assists to understand the regional market and the strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Key Market Segments

By Media Type

  • Serum-containing Media
  • Serum-free Media
  • Stem Cell Media
  • Specialty Media
  • Chemically Defined Media
  • Lysogeny Broth
  • Custom Media
  • Others

By Viral Vectors Type

  • Retroviruses
  • Lentiviruses
  • Adenoviruses
  • Adeno-associated Virus
  • Herpes Simplex Virus
  • Poxvirus
  • Vaccinia Virus
  • Others

By End-User

  • Biotechnology & Pharmaceutical Industry
  • Academic Institute
  • Research Laboratory
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players in the Gene Therapy Cell Culture Media Market

  • Fujifilm Holdings Corporation
  • HiMedia Laboratories Pvt., Ltd
  • Lonza Group Ltd
  • Sartorius AG (S
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Takara Holdings Inc.
  • Novartis International AG
  • Bio-Techne Corporation
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.1.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Top player positioning
3.4.Porter’s five forces analysis
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Rise in R&D investments
3.5.1.2.Growth in awareness regarding gene therapy
3.5.1.3.Increase in advancements associated gene therapy
3.5.1.4.Increase in prevalence of cancer
3.5.2.Restraints
3.5.2.1.Dearth of skilled professionals
3.5.2.2.High cost associated with gene therapies
3.5.2.3.Ethical & scientific concerns associated with culture media
3.5.3.Opportunity
3.5.3.1.Untapped potential of the emerging economies
3.6.Impact Analysis of COVID-19 on Gene Therapy Cell Culture Media Market
CHAPTER 4:GENE THERAPY CELL CULTURE MEDIA MARKET, BY
MEDIA TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Serum-containing media
4.2.1.Market size and forecast, by region
4.2.2.Market analysis by country
4.3.Serum-free media
4.3.1.Market size and forecast, by region
4.3.2.Market analysis by country
4.4.Stem cell media
4.4.1.Market size and forecast, by region
4.4.2.Market analysis by country
4.5.Specialty media
4.5.1.Market size and forecast, by region
4.5.2.Market analysis by country
4.6.Chemically defined media
4.6.1.Market size and forecast, by region
4.6.2.Market analysis by country
4.7.Lysogeny broth
4.7.1.Market size and forecast, by region
4.7.2.Market analysis by country
4.8.Custom media
4.8.1.Market size and forecast, by region
4.8.2.Market analysis by country
4.9.Other media
4.9.1.Market size and forecast, by region
4.9.2.Market analysis by country
CHAPTER 5:GENE THERAPY CELL CULTURE MEDIA MARKET, BY
VIRAL VECTORS TYPE
5.1.Overview
5.1.1.Market size and forecast
5.2.Retroviruses
5.2.1.Market size and forecast, by region
5.2.2.Market analysis by country
5.3.Lentiviruses
5.3.1.Market size and forecast, by region
5.3.2.Market analysis by country
5.4.Adenoviruses
5.4.1.Market size and forecast, by region
5.4.2.Market analysis by country
5.5.Adeno associated virus
5.5.1.Market size and forecast, by region
5.5.2.Market analysis by country
5.6.Herpes simplex virus
5.6.1.Market size and forecast, by region
5.6.2.Market analysis by country
5.7.Poxvirus
5.7.1.Market size and forecast, by region
5.7.2.Market analysis by country
5.8.Vaccinia virus
5.8.1.Market size and forecast, by region
5.8.2.Market analysis by country
5.9.Others
5.9.1.Market size and forecast, by region
5.9.2.Market analysis by country
CHAPTER 6:GENE THERAPY CELL CULTURE MEDIA MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Pharmaceutical & biotechnology Industries
6.2.1.Market size and forecast, by region
6.2.2.Market analysis by country
6.3.Research Laboratories
6.3.1.Market size and forecast, by region
6.3.2.Market analysis by country
6.4.Academic Institutions
6.4.1.Market size and forecast, by region
6.4.2.Market analysis by country
6.5.Others
6.5.1.Market size and forecast, by region
6.5.2.Market analysis by country
CHAPTER 7:GENE THERAPY CELL CULTURE MEDIA MARKET, BY REGION
7.1.OVERVIEW
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.North America cell culture market, by country
7.2.2.1.U.S. gene therapy cell culture media market, by media type
7.2.2.2.U.S. gene therapy cell culture media market, by viral vectors type
7.2.2.3.U.S. gene therapy cell culture media market, by end user
7.2.2.4.Canada gene therapy cell culture media market, by media type
7.2.2.5.Canada gene therapy cell culture media market, by viral
vectors type
7.2.2.6.Canada gene therapy cell culture media market, by end user
7.2.2.7.Mexico gene therapy cell culture media market, by media type
7.2.2.8.Mexico gene therapy cell culture media market, by viral vectors type
7.2.2.9.Mexico gene therapy cell culture media market, by end user
7.2.3.North America gene therapy cell culture media market, by media type
7.2.4.North America gene therapy cell culture media market, by viral
vectors type
7.2.5.North America gene therapy cell culture media market, by end user
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Europe gene therapy cell culture media market, by country
7.3.2.1.Germany gene therapy cell culture media market, by media type
7.3.2.2.Germany gene therapy cell culture media market, by viral
vectors type
7.3.2.3.Germany gene therapy cell culture media market, by end user
7.3.2.4.France gene therapy cell culture media market, by media type
7.3.2.5.France gene therapy cell culture media market, by viral vectors type
7.3.2.6.France gene therapy cell culture media market, by end user
7.3.2.7.UK gene therapy cell culture media market, by media type
7.3.2.8.UK gene therapy cell culture media market, by viral vectors type
7.3.2.9.Uk gene therapy cell culture media market, by end user
7.3.2.10.Italy gene therapy cell culture media market, by media type
7.3.2.11.Italy gene therapy cell culture media market, by viral vectors type
7.3.2.12.Italy gene therapy cell culture media market, by end user
7.3.2.13.Spain gene therapy cell culture media market, by media type
7.3.2.14.Spain gene therapy cell culture media market, by viral vectors type
7.3.2.15.Spain gene therapy cell culture media market, by end user
7.3.2.16.Rest of Europe gene therapy cell culture media market,
by media type
7.3.2.17.Rest of Europe gene therapy cell culture media market,
by viral vectors type
7.3.2.18.Rest of Europe gene therapy cell culture media market, by end user
7.3.3.Europe gene therapy cell culture media market, by media type
7.3.4.Europe gene therapy cell culture media market, by viral vectors type
7.3.5.Europe gene therapy cell culture media market, by end user
7.4.Asia-Pacifi
7.4.1.Key market trends and opportunities
7.4.2.Asia-Pacific gene therapy cell culture media market, by country
7.4.2.1.China gene therapy cell culture media market, by media type
7.4.2.2.China gene therapy cell culture media market, by viral vectors type
7.4.2.3.China gene therapy cell culture media market, by end user
7.4.2.4.Japan gene therapy cell culture media market, by media type
7.4.2.5.Japan gene therapy cell culture media market, by viral vectors type
7.4.2.6.Japan gene therapy cell culture media market, by end user
7.4.2.7.Australia gene therapy cell culture media market, by media type
7.4.2.8.Australia gene therapy cell culture media market, by viral
vectors type
7.4.2.9.Australia gene therapy cell culture media market, by end user
7.4.2.10.India gene therapy cell culture media market, by media type
7.4.2.11.India gene therapy cell culture media market, by viral vectors type
7.4.2.12.India gene therapy cell culture media market, by end user
7.4.2.13.South Korea gene therapy cell culture media market, by media type
7.4.2.14.South Korea gene therapy cell culture media market, by viral
vectors type
7.4.2.15.South Korea gene therapy cell culture media market, by end user
7.4.2.16.Rest of Asia-Pacific gene therapy cell culture media market,
by media type
7.4.2.17.Rest of Asia-Pacific gene therapy cell culture media market,
by viral vectors type
7.4.2.18.Rest of Asia- Pacific gene therapy cell culture media market,
by end user
7.4.3.Asia- Pacific gene therapy cell culture media market, by media type
7.4.4.Asia- Pacific gene therapy cell culture media market, by
viral vectors type
7.4.5.Asia- Pacific gene therapy cell culture media market, by end user
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.LAMEA gene therapy cell culture media market, by country
7.5.2.1.Brazil gene therapy cell culture media market, by media type
7.5.2.2.Brazil gene therapy cell culture media market, by viral vectors type
7.5.3.Brazil gene therapy cell culture media market, by end user
7.5.3.1.Saudi Arabia gene therapy cell culture media market,
by media type
7.5.3.2.Saudi Arabia gene therapy cell culture media market, by
viral vectors type
7.5.4.Saudi Arabia gene therapy cell culture media market, by end user
7.5.4.1.South Africa gene therapy cell culture media market, by media type
7.5.4.2.South Africa gene therapy cell culture media market, by viral
vectors type
7.5.5.South Africa gene therapy cell culture media market, by end user
7.5.5.1.Rest of LAMEA gene therapy cell culture media market,
by media type
7.5.5.2.Rest of LAMEA gene therapy cell culture media market, by
viral vectors type
7.5.6.REST OF LAMEA gene therapy cell culture media market, by end user
7.5.7.LAMEA gene therapy cell culture media market, by media type
7.5.8.LAMEA gene therapy cell culture media market, by viral vectors type
7.5.9.LAMEA gene therapy cell culture media market, by end user
CHAPTER 8:COMPANY PROFILES
8.1.BIO-TECHNE CORPORATION
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Operating product portfolio
8.1.5.Business performance
8.2.DANAHER CORPORATION (CYTIVA)
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.3.FUJIFILM HOLDINGS CORPORATION (FUJIFILM IRVINE SCIENTIFIC)
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.HIMEDIA LABORATORIES
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.5.LONZA GROUP LTD
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Operating product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.MERCK KGAA
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.NOVARTIS INTERNATIONAL AG
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.SARTORIUS AG
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.9.THERMO FISHER SCIENTIFIC, INC.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.TAKARA HOLDINGS INC. (TAKARA BIO INC.)
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performanc

List Of Tables

 

Table 01.Gene Therpay Cell Culture Media Market By Media Type 2019-2027, ($Million)

Table 02.Gene Therapy Cell Culture Media Market For Serum Containing Media, By Region

2019–2027($Million)

Table 03.Gene Therapy Cell Culture Media Market For Serum Free Media, By Region

2019–2027($Million)

Table 04.Gene Therapy Cell Culture Media Market For Stem Cell Media, By Region

2019–2027($Million)

Table 05.Gene Therapy Cell Culture Media Market For Specialty Media, By Region

2019–2027($Million)

Table 06.Gene Therapy Cell Culture Media Market For Chemically Defined Media,

By Region 2019–2027($Million)

Table 07.Gene Therapy Cell Culture Media Market For Lysogeny Broth, By Region

2019–2027($Million)

Table 08.Gene Therapy Cell Culture Media Market For Custom Media, By Region

2019–2027($Million)

Table 09.Gene Therapy Cell Culture Media Market For Other Media, By Region

2019–2027($Million)

Table 10.Gene Therpay Cell Culture Media Market By Viral Vector Type 2019-2027, ($Million)

Table 11.Gene Therapy Cell Culture Media Market For Retroviruses, By Region

2019–2027($Million)

Table 12.Gene Therapy Cell Culture Media Market For Lentiviruses, By Region

2019–2027($Million)

Table 13.Gene Therapy Cell Culture Media Market For Adenoviruses, By Region

2019–2027($Million)

Table 14.Gene Therapy Cell Culture Media Market For Adeno Associated Virus, By Region

2019–2027($Million)

Table 15.Gene Therapy Cell Culture Media Market For Herpes Simplex Virus, By Region

2019–2027($Million)

Table 16.Gene Therapy Cell Culture Media Market For Poxvirus, By Region 2019–2027($Million)

Table 17.Gene Therapy Cell Culture Media Market For Vaccinia Virus, By Region

2019–2027($Million)

Table 18.Gene Therapy Cell Culture Media Market For Others, By Region 2019–2027($Million)

Table 19.Gene Therapy Cell Culture Media Market, By End User, 2019-2027 ($Million)

Table 20.Gene Therapy Cell Culture Media Market For Pharmaceutical & Biotechnology

Industries, By Region 2019–2027($Million)

Table 21.Gene Therapy Cell Culture Media Market For Research Laboratories, By Region

2019–2027 ($Million)

Table 22.Gene Therapy Cell Culture Media Market For Academic Institutions, By Region

2019–2027 ($Million)

Table 23.Gene Therapy Cell Culture Media Market For Others, By Region 2019–2027 ($Million)

Table 24.Gene Therapy Cell Culture Media Market Revenue, By Region, 2019–2027($Million)

Table 25.North America Gene Therapy Cell Culture Media Market, By Country,

2019–2027($Million)

Table 26.U.S. Gene Therapy Cell Culture Media Market, By Media Type, 2019–2027($Million)

Table 27.U.S. Gene Therpay Cell Culture Media Market By Viral Vector Type 2019-2027, ($Million)

Table 28.U.S. Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 29.Canada Gene Therapy Cell Culture Media Market, By Media Type, 2019–2027($Million)

Table 30.Canada Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 31.Canada Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 32.Mexico Gene Therapy Cell Culture Media Market, By Media Type, 2019–2027($Million)

Table 33.Mexico Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 34.Mexico Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 35.North America Gene Therapy Cell Culture Media Market, By Media Type,

2019–2027($Million)

Table 36.North America Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 37.North America Gene Therapy Cell Culture Media Market, By End User,

2019–2027($Million)

Table 38.Europe Gene Therapy Cell Culture Media Market, By Country, 2019–2027($Million)

Table 39.Germany Gene Therapy Cell Culture Media Market, By Media Type, 2019–2027($Million)

Table 40.Germany Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 41.Germany Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 42.France Gene Therapy Cell Culture Media Market, By Media Type, 2019–2027($Million)

Table 43.France Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 44.France Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 45.Uk Gene Therapy Cell Culture Media Market, By Media Type, 2019–2027($Million)

Table 46.Uk Gene Therpay Cell Culture Media Market By Viral Vector Type 2019-2027, ($Million)

Table 47.Uk Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 48.Italy Gene Therapy Cell Culture Media Market, By Media Type, 2019–2027($Million)

Table 49.Italy Gene Therpay Cell Culture Media Market By Viral Vector Type 2019-2027, ($Million)

Table 50.Italy Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 51.Spain Gene Therapy Cell Culture Media Market, By Media Type, 2019–2027($Million)

Table 52.Spain Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 53.Spain Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 54.Rest Of Europe Gene Therapy Cell Culture Media Market, By Media Type,

2019–2027($Million)

Table 55.Rest Of Europe Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 56.Rest Of Europe Gene Therapy Cell Culture Media Market, By End User,

2019–2027($Million)

Table 57.Europe Gene Therapy Cell Culture Media Market, By Media Type, 2019–2027($Million)

Table 58.Europe Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 59.Europe Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 60.Asia-Pacific Gene Therapy Cell Culture Media Market, By Country, 2019–2027($Million)

Table 61.China Gene Therapy Cell Culture Media Market, By Media Type, 2019–2027($Million)

Table 62.China Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 63.China Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 64.Japan Gene Therapy Cell Culture Media Market, By Media Type, 2019–2027($Million)

Table 65.Japan Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 66.Japan Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 67.Australia Gene Therapy Cell Culture Media Market, By Media Type, 2019–2027($Million)

Table 68.Australia Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 69.Australia Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 70.India Gene Therapy Cell Culture Media Market, By Media Type, 2019–2027($Million)

Table 71.India Gene Therpay Cell Culture Media Market By Viral Vector Type 2019-2027, ($Million)

Table 72.India Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 73.South Korea Gene Therapy Cell Culture Media Market, By Media Type,

2019–2027($Million)

Table 74.South Korea Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 75.South Korea Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 76.Rest Of Asia-Pacific Gene Therapy Cell Culture Media Market, By Media Type,

2019–2027($Million)

Table 77.Rest Of Asia-Pacific Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 78.Rest Of Asia Pacific Gene Therapy Cell Culture Media Market, By End User,

2019–2027($Million)

Table 79.Asia-Pacific Gene Therapy Cell Culture Media Market, By Media Type,

2019–2027($Million)

Table 80.Asia Pacific Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 81.Asia- Pacifc Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 82.Lamea Gene Therapy Cell Culture Media Market, By Country, 2019–2027($Million)

Table 83.Brazil Gene Therapy Cell Culture Media Market, By Media Type, 2019–2027($Million)

Table 84.Brazil Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 85.Brazil Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 86.Saudi Arabia Gene Therapy Cell Culture Media Market, By Media Type,

2019–2027($Million)

Table 87.Saudi Arabia Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 88.Saudi Arabia Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 89.South Africa Gene Therapy Cell Culture Media Market, By Media Type,

2019–2027($Million)

Table 90.South Africa Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 91.South Africa Gene Therapy Cell Culture Media Market, By End User,

2019–2027($Million)

Table 92.Rest Of Lamea Gene Therapy Cell Culture Media Market, By Media Type,

2019–2027($Million)

Table 93.Rest Of Lamea Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 94.Rest Of Lamea Gene Therapy Cell Culture Media Market, By End User,

2019–2027($Million)20

Table 95.Lamea Gene Therapy Cell Culture Media Market, By Media Type, 2019–2027($Million)

Table 96.Asia Pacific Gene Therpay Cell Culture Media Market By Viral Vector Type

2019-2027, ($Million)

Table 97.Lamea Gene Therapy Cell Culture Media Market, By End User, 2019–2027($Million)

Table 98.Bio-Techne: Company Snapshot

Table 99.Operating Business Segment

Table 100.Bio-Techne: Product Portfolio

Table 101.Danaher: Company Snapshot

Table 102.Danaher: Operating Segment

Table 103.Ge Healthcare: Product Portfolio

Table 104.Fujifilm: Company Snapshot

Table 105.Fujifilm: Operating Segments

Table 106.Fujifilm: Product Portfolio

Table 107.Himedia: Company Snapshot

Table 108.Himedia:Operating Product Segment

Table 109.Himedia: Product Portfolio

Table 110.Lonza: Company Snapshot

Table 111.Product Portfolio

Table 112.Lonza: Product Portfolio

Table 113.Sartorius: Key Strategic Moves And Developments

Table 114.Merck: Company Snapshot

Table 115.Merck: Operating Segments

Table 116.Merck: Product Portfolio

Table 117.Sartorius: Key Strategic Moves And Developments

Table 118.Novartis: Company Snapshot

Table 119.Novartis: Operating Segments

Table 120.Novartis: Product Portfolio

Table 121.Sartorius: Company Snapshot

Table 122.Sartorius: Operating Business Segments

Table 123.Sartorius: Product Portfolio

Table 124.Thermo Fisher: Company Snapshot

Table 125.Thermo Fisher.: Operating Segments

Table 126.Thermo Fisher.: Product Portfolio

Table 127.Thermo Fisher Scientific : Key Strategic Moves And Developments

Table 128.Takara Group: Company Snapshot

Table 129.Takara Group: Operating Segments

Table 130.Takara Group: Product Portfolio List Of Figures

 

Figure 01.Gene Therapy Cell Culture Media Marketsegmentation

Figure 02.Top Investment Pockets

Figure 03.Top Winning Strategies, By Year, 2018-2020*

Figure 04.Top Winning Strategies, By Development, 2018-2020*

Figure 05.Top Winning Strategies, By Company, 2018-2020*

Figure 06.Moderate Bargaining Power Of Buyers

Figure 07.Low Bargaining Power Of Suppliers

Figure 08.Moderate Threat Of New Entrants

Figure 09.Low Threat Of Substitution

Figure 10.Moderate Competitive Rivalry

Figure 11.Drivers, Restraints, And Opportunities

Figure 12.Gene Therapy Pipeline Volume, Preclinical Through Pre-Registration Phase, 1995–2018

Figure 13.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Serum Containing Media, By Country, 2019 & 2027 (%)

Figure 14.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Serum Free Media, By Country, 2019 & 2027 (%)

Figure 15.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Stem Cell Media, By Country, 2019 & 2027 (%)

Figure 16.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Specialty Media, By Country, 2019 & 2027 (%)

Figure 17.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Chemically Defined Media, By Country, 2019 & 2027 (%)

Figure 18.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Lysogeny Broth, By Country, 2019 & 2027 (%)

Figure 19.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Custom Media, By Country, 2019 & 2027 (%)

Figure 20.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Other Media, By Country, 2019 & 2027 (%)

Figure 21.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Retroviruses, By Country, 2019 & 2027 (%)

Figure 22.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Lentiviruses, By Country, 2019 & 2027 (%)

Figure 23.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Adenoviruses, By Country, 2019 & 2027 (%)

Figure 24.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Adeno Associated Virus, By Country, 2019 & 2027 (%)

Figure 25.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Herpes Simplex Virus, By Country, 2019 & 2027 (%)

Figure 26.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Poxvirus, By Country, 2019 & 2027 (%)

Figure 27.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Vaccinia Virus, By Country, 2019 & 2027 (%)

Figure 28.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Others, By Country, 2019 & 2027 (%)

Figure 29.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Pharmaceutical & Biotechnology Industries, By Country, 2019 & 2027 (%)

Figure 30.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Research Laboratories, By Country, 2019 & 2027 (%)

Figure 31.Comparative Share Analysis Of Cell Culture Market For Academic Institutions,

By Country, 2019 & 2027 (%)

Figure 32.Comparative Share Analysis Of Gene Therapy Cell Culture Media Market For

Others, By Country, 2019 & 2027 (%)

Figure 33.Bio-Techne: Net Sales, 2017–2019 ($Million)

Figure 34.Bio-Techne: Revenue Share, By Segment, 2019 (%)

Figure 35.Bio-Techne: Revenue Share, By Region, 2019 (%)

Figure 36.Danaher: Net Sales, 2017–2019 ($Million)

Figure 37.Danaher: Revenue Share, By Segment, 2019 (%)

Figure 38.Danaher: Revenue Share, By Region, 2019 (%)

Figure 39.Fujifilm: Net Sales, 2018–2020 ($Million)

Figure 40.Fujifilm: Revenue Share, By Segment, 2020 (%)

Figure 41.Lonza: Net Sales, 2017–2019 ($Million)

Figure 42.Lonza: Revenue Share, By Segment, 2019 (%)

Figure 43.Merck: Net Sales, 2017–2019 ($Million)

Figure 44.Merck: Revenue Share, By Segment, 2019 (%)

Figure 45.Merck: Revenue Share, By Region, 2019 (%)

Figure 46.Novartis: Net Sales, 2017–2019 ($Million)

Figure 47.Novartis: Revenue Share, By Segment, 2019 (%)

Figure 48.Novartis: Revenue Share, By Region, 2019 (%)

Figure 49.Sartorius: Net Sales, 2017–2019 ($Million)

Figure 50.Sartorius: Revenue Share By Segment, 2019 (%)

Figure 51.Sartorius: Revenue Share By Region, 2019 (%)

Figure 52.Thermo Fisher: Net Sales, 2017–2019 ($Million)

Figure 53.Thermo Fisher: Revenue Share, By Segment, 2019 (%)

Figure 54.Thermo Fisher: Revenue Share, By Region, 2019 (%)

Figure 55.Takara Group: Net Sales, 2017–2019 ($Million)

Figure 56.Takara Group: Revenue Share, By Segment, 2019 (%

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$6168
This license allows only one user to access the PDF.

Electronic (PDF)
$6929
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9663
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Electronic (Excel)
$4125
This license allows users/teams to use the numbers mentioned in the Excel sheet within an organisation
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global Electrochemical Deburring Machine Market Insights and Forecast to 2028
Global Electrochemical Deburring Machine Market Insights and Forecast to 2028

Market Analysis and Insights Global Electrochemical Deburring Machine MarketDue to the COVID19 pandemic the global Electrochemical Deburring Machine market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-19U8790
Mon Jan 31 00:00:00 UTC 2022

Add to Cart

Global Pharmaceutical Rigid Packaging Market Insights and Forecast to 2028
Global Pharmaceutical Rigid Packaging Market Insights and Forecast to 2028

Market Analysis and Insights Global Pharmaceutical Rigid Packaging MarketDue to the COVID19 pandemic the global Pharmaceutical Rigid Packaging market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-9N9612
Mon Jan 31 00:00:00 UTC 2022

Add to Cart

Global In Vitro Toxicology Toxicity Testing Market Insights and Forecast to 2028
Global In-Vitro Toxicology/ Toxicity Testing Market Insights and Forecast to 2028

Market Analysis and Insights Global InVitro Toxicology Toxicity Testing MarketThe global InVitro Toxicology Toxicity Testing market size is projected to reach US 17060 million by 2028 from US 9889.1 million in 2021 at a CAGR of 8.0 during 20222028.Fully considering the economic change by this health crisis Cell Culture Technology accounting for of the InVitro Toxicology Toxicity Testing global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

120 Pages
Type: Report
Code: QYRE-Auto-20B6006
Mon Jan 31 00:00:00 UTC 2022

Add to Cart

Global Hemodialysis Device Market Insights and Forecast to 2028
Global Hemodialysis Device Market Insights and Forecast to 2028

Market Analysis and Insights Global Hemodialysis Device MarketThe global Hemodialysis Device market size is projected to reach US 26970 million by 2028 from US 21110 million in 2021 at a CAGR of 3.5 during 20222028.Fully considering the economic change by this health crisis Hemodialysis Machine accounting for of the Hemodialysis Device global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

120 Pages
Type: Report
Code: QYRE-Auto-29T5923
Mon Jan 31 00:00:00 UTC 2022

Add to Cart